✦ LIBER ✦

Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes

✍ Scribed by Stearns, V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tamoxifen Metabolite Concentrations, CYP

✍ Madlensky, L; Natarajan, L; Tchu, S; Pu, M; Mortimer, J; Flatt, S W; Nikoloff, D 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB

CYP2D6 genotype affects outcome in postm

✍ AM Thompson, S Bray, AM Johnson, P Quinlan, DM Nikloff, DG Evans… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 390 KB

4–35 CYP2D6 Genotype, Antidepressant Use

✍ Diasio, R.B. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Comprehensive CYP2D6 genotype and adhere

✍ Alastair M. Thompson; Andrea Johnson; Philip Quinlan; Grantland Hillman; Marcel 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 321 KB

Association between CYP2D6 *10 genotype

✍ Xu, Y.; Sun, Y.; Yao, L.; Shi, L.; Wu, Y.; Ouyang, T.; Li, J.; Wang, T.; Fan, Z. 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 110 KB

CYP2C19*2predicts substantial tamoxifen

✍ K. Beelen, M. Opdam, T. M. Severson, R. H. T. Koornstra, A. D. Vincent, M. Haupt 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 263 KB